December 20, 2022
The McAllister Heart Institute received “Institutional Award for Undergraduate Student Training” by the American Heart Association. The $165K award will fund five summer researchers annually.
November 30, 2022
The UNC School of Medicine lab of Bryan L. Roth, MD, PhD, solved the high-resolution, complex structures of drug-like compounds bound to designer brain cell receptors, paving the way for the creation of next-generation chemogenetic tools. Postdoc Shicheng Zhang, PhD, led this research published in Nature.
November 22, 2022
Jacqueline Halladay, MD, MPH, from UNC Family Medicine, and Doyle “Skip” Cummings, PharmD, from the ECU Brody School of Medicine, are leading a five-year, $5.6 million PCORI grant to understand if a technology-enabled team-based approach results in greater blood pressure control compared to usual care in populations of people with uncontrolled high blood pressure.
November 9, 2022
The European Society of Gene and Cell Therapy honored the UNC School of Medicine’s Jude Samulski, PhD, co-founder and chief science officer of AskBio, with its inaugural Founder’s Award.
September 28, 2022
A research team from UNC-Chapel Hill, UC San Francisco, Yale, Duke, and Stanford developed a new compound that hits the same brain cell target as psychedelic drugs, triggering long-lasting anti-depressant action without psychedelic effects in mice.
July 27, 2022
The UNC School of Medicine lab of Bryan Roth, MD, PhD, found variants in one tiny serotonin receptor in neurons, and these variants could be why some patients fare much better after psychedelic therapy than other patients.
July 5, 2022
Mauro Calabrese, PhD, Nilu Goonetilleke, PhD, and Adam Hantman, PhD, were selected as Yang Family Biomedical Scholars in the sixth installment of this annual School of Medicine award.
May 16, 2022
Led by Juan Song, PhD, scientists at the UNC School of Medicine used optogenetic techniques to stimulate specific brain cells to increase production of neural stem cells and neurons relevant to memory and emotion processing in animal models.
February 3, 2022
UNC researchers optimized the function of a microscope for cryogenic electron microscopy (CryoEM) to maximize the throughput and performance of the microscope housed in the UNC Chapel Hill Cryo-EM Core Facility. This method development is demonstrated successful for structural studies of GPCRs, a large group of signaling proteins that includes many therapeutic targets with unknown structures.
January 26, 2022
Current therapeutic options and resources to aid appropriate selection.
December 15, 2021
Scientists at UNC-Chapel Hill led by Bryan L. Roth, MD, PhD, and colleagues from the University of Southern California and Northeastern University, have created and validated V-SYNTHES – a computational method to quickly screen billions of theoretical compounds for researchers to explore as potential therapies. Their work was published in Nature.
December 7, 2021
AdvanTx would like to distribute two external corporate collaboration opportunities for faculty - The Johnson and Johnson Quickfire Challenge for immune-mediated diseases and a Beta-Propellor Proteins Discovery Opportunity.